Vivos Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $4.8M | — |
| Dec 2019 | $3.7M | $-2.9M | $469.4K |
| Mar 2020 | — | $-1.5M | — |
| Jun 2020 | — | $-2.2M | — |
| Sep 2020 | — | $-1.9M | — |
| Dec 2020 | $423.0K | $16.9M | $18.2M |
| Mar 2021 | $105.9K | $14.3M | $14.1M |
| Jun 2021 | $1.3M | $36.5M | $34.2M |
| Sep 2021 | $1.3M | $32.5M | $28.5M |
| Dec 2021 | $1.3M | $25.5M | $24.0M |
| Mar 2022 | — | $21.0M | $17.8M |
| Jun 2022 | — | $14.8M | $12.7M |
| Sep 2022 | — | $9.9M | $6.7M |
| Dec 2022 | — | $4.8M | $3.5M |
| Mar 2023 | — | $7.0M | $7.0M |
| Jun 2023 | — | $2.1M | $3.9M |
| Sep 2023 | — | $46.0K | $988.0K |
| Dec 2023 | — | $411.0K | $1.6M |
| Mar 2024 | — | $582.0K | $2.6M |
| Jun 2024 | — | $6.3M | $6.9M |
| Sep 2024 | — | $7.7M | $6.3M |
| Dec 2024 | — | $8.0M | $6.3M |
| Mar 2025 | — | $4.4M | $2.3M |
| Jun 2025 | $7.8M | $4.6M | $4.4M |
| Sep 2025 | $8.4M | $2.5M | $3.1M |
| Dec 2025 | $469.0K | $-1.5M | $2.0M |
| Mar 2026 | $418.0K | $-1.1M | $2.1M |
| Jun 2026 | $366.0K | $-3.8M | $1.8M |